Product Program year 2020 Source: CMS Open Payments

Kengreal 50Mg/10Ml L

Drug Cardiovascular

NDC 10122-620-10

Open in the dashboard

General payments

$50,973

2,312 payments

Research payments

$0

0 payments

Through program year 2020, $50,973 in general payments and $0 in research payments were reported against Kengreal 50Mg/10Ml L (Cardiovascular).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2020 General $50,973 2,312

Breakdown

Who paid General payments · program year 2020
  1. Chiesi USA, Inc. $50,973 2,312 payments
Top recipients General payments · program year 2020
  1. David Kong Cardiovascular Disease · Durham, NC $2,829 6% · 6 payments
  2. Rajesh Dave Cardiovascular Disease · Camp Hill, PA $624 1% · 10 payments
  3. Amir Piracha Cardiovascular Disease · Louisville, KY $477 <1% · 11 payments
  4. John Lasala Interventional Cardiology · Saint Louis, MO $470 <1% · 2 payments
  5. Prakash Balan Interventional Cardiology · Chandler, AZ $423 <1% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Cardiovascular Disease Internal Medicine $22,733 45% · 510 practitioners
  2. Interventional Cardiology Internal Medicine $18,239 36% · 444 practitioners
  3. Clinical Cardiac Electrophysiology Internal Medicine $1,747 3% · 56 practitioners
  4. Anesthesiology $1,490 3% · 65 practitioners
  5. Internal Medicine $1,459 3% · 38 practitioners

The top 5 of 40 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. California $6,946 14% · 137 recipients
  2. New York $5,058 10% · 121 recipients
  3. North Carolina $4,310 8% · 33 recipients
  4. Texas $4,011 8% · 124 recipients
  5. Illinois $3,071 6% · 57 recipients

The top 5 of 48 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

2,312 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record